Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Accuracy of first-trimester cell-free DNA screening for trisomy 21 in twin pregnancy.
Gottardi E, Costa JM, Kleinfinger P, Lohmann L, Carrara J, Letourneau A, Demain A, Benachi A, Vivanti AJ. Gottardi E, et al. Among authors: letourneau a. Ultrasound Obstet Gynecol. 2021 Aug;58(2):327-328. doi: 10.1002/uog.23102. Ultrasound Obstet Gynecol. 2021. PMID: 32865843 Free article. No abstract available.
[Fetal DNA in maternal plasma and serum].
Letourneau A, Costa JM, Benachi A. Letourneau A, et al. Gynecol Obstet Fertil. 2015 Feb;43(2):163-5. doi: 10.1016/j.gyobfe.2014.12.016. Epub 2015 Jan 15. Gynecol Obstet Fertil. 2015. PMID: 25600274 French. No abstract available.
Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination.
Benachi A, Letourneau A, Kleinfinger P, Senat MV, Gautier E, Favre R, Bidat L, Houfflin-Debarge V, Bouyer J, Costa JM; Collaborative SEquençage a Haut Debit et Aneuploidies (SEHDA) Study Group. Benachi A, et al. Among authors: letourneau a. Obstet Gynecol. 2015 Jun;125(6):1330-1337. doi: 10.1097/AOG.0000000000000874. Obstet Gynecol. 2015. PMID: 26000504 Clinical Trial.
[Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France].
Benachi A, Letourneau A, Kleinfinger P, Senat MV, Gautier E, Favre R, Bidat L, Houfflin-Debarge V, Querol V, Bouyer J, Costa JM; pour le groupe SEHDA. Benachi A, et al. Among authors: letourneau a. J Gynecol Obstet Biol Reprod (Paris). 2016 Jun;45(6):633-40. doi: 10.1016/j.jgyn.2015.08.003. Epub 2015 Oct 27. J Gynecol Obstet Biol Reprod (Paris). 2016. PMID: 26518155 French.
Cell-free fetal DNA versus maternal serum screening for trisomy 21 in pregnant women with and without assisted reproduction technology: a prospective interventional study.
Costa JM, Letourneau A, Favre R, Bidat L, Belaisch-Allart J, Jouannic JM, Quarello E, Senat MV, Broussin B, Tsatsaris V, Demain A, Kleinfinger P, Lohmann L, Agostini H, Bouyer J, Benachi A. Costa JM, et al. Among authors: letourneau a. Genet Med. 2018 Nov;20(11):1346-1353. doi: 10.1038/gim.2018.4. Epub 2018 Mar 1. Genet Med. 2018. PMID: 29493578 Free article.
Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.
Bevilacqua E, Jani JC, Letourneau A, Duiella SF, Kleinfinger P, Lohmann L, Resta S, Cos Sanchez T, Fils JF, Mirra M, Benachi A, Costa JM. Bevilacqua E, et al. Among authors: letourneau a. Fetal Diagn Ther. 2019;45(5):302-311. doi: 10.1159/000489124. Epub 2018 Jun 13. Fetal Diagn Ther. 2019. PMID: 29898450
113 results